BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tanaka T, Fujita H, Matono S, Nagano T, Nishimura K, Murata K, Shirouzu K, Suzuki G, Hayabuchi N, Yamana H. Outcomes of multimodality therapy for stage IVB esophageal cancer with distant organ metastasis (M1-Org). Dis Esophagus 2010;23:646-51. [PMID: 20545979 DOI: 10.1111/j.1442-2050.2010.01069.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Wu SG, Xie WH, Zhang ZQ, Sun JY, Li FY, Lin HX, Yong Bao, He ZY. Surgery Combined with Radiotherapy Improved Survival in Metastatic Esophageal Cancer in a Surveillance Epidemiology and End Results Population-based Study. Sci Rep 2016;6:28280. [PMID: 27323696 DOI: 10.1038/srep28280] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
2 Procopio F, Marano S, Gentile D, Da Roit A, Basato S, Riva P, De Vita F, Torzilli G, Castoro C. Management of Liver Oligometastatic Esophageal Cancer: Overview and Critical Analysis of the Different Loco-Regional Treatments. Cancers (Basel) 2019;12:E20. [PMID: 31861604 DOI: 10.3390/cancers12010020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
3 Zhang R, Zou J, Li P, Li Q, Qiao Y, Han J, Huang K, Ruan P, Lin H, Song Q, Fu Z. Surgery to the primary tumor is associated with improved survival of patients with metastatic esophageal cancer: propensity score-matched analyses of a large retrospective cohort. Diseases of the Esophagus 2019. [DOI: 10.1093/dote/doz051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
4 Ikeda E, Kojima T, Kaneko K, Minashi K, Onozawa M, Nihei K, Fuse N, Yano T, Yoshino T, Tahara M, Doi T, Ohtsu A. Efficacy of concurrent chemoradiotherapy as a palliative treatment in stage IVB esophageal cancer patients with dysphagia. Jpn J Clin Oncol 2011;41:964-72. [PMID: 21742654 DOI: 10.1093/jjco/hyr088] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
5 Li H, Zhang S, Guo J, Zhang L. Hepatic Metastasis in Newly Diagnosed Esophageal Cancer: A Population-Based Study. Front Oncol 2021;11:644860. [PMID: 34041021 DOI: 10.3389/fonc.2021.644860] [Reference Citation Analysis]
6 Kakuta T, Kosugi SI, Ichikawa H, Hanyu T, Ishikawa T, Kanda T, Wakai T. Palliative interventions for patients with incurable locally advanced or metastatic thoracic esophageal carcinoma. Esophagus 2019;16:278-84. [PMID: 30949884 DOI: 10.1007/s10388-019-00665-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
7 Qiu G, Zhang H, Wang F, Zheng Y, Wang Z, Wang Y. Metastasis Patterns and Prognosis of Elderly Patients With Esophageal Adenocarcinoma in Stage IVB: A Population-Based Study. Front Oncol 2021;11:625720. [PMID: 34123784 DOI: 10.3389/fonc.2021.625720] [Reference Citation Analysis]
8 Guo J, Zhang S, Li H, Hassan MOO, Lu T, Zhao J, Zhang L. Lung Metastases in Newly Diagnosed Esophageal Cancer: A Population-Based Study. Front Oncol 2021;11:603953. [PMID: 33718154 DOI: 10.3389/fonc.2021.603953] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Seyedin SN, Parekh KR, Ginader T, Caster JM. The Role of Definitive Radiation and Surgery in Metastatic Esophageal Cancer: An NCDB Investigation. Ann Thorac Surg 2021;112:459-66. [PMID: 33096068 DOI: 10.1016/j.athoracsur.2020.08.034] [Reference Citation Analysis]
10 Land CF, Bowden BD, Morpeth BG, DeVine JG. Intradural extramedullary metastasis: a review of literature and case report. Spinal Cord Ser Cases 2019;5:41. [PMID: 31632701 DOI: 10.1038/s41394-019-0181-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
11 Janmaat VT, Steyerberg EW, van der Gaast A, Mathijssen RH, Bruno MJ, Peppelenbosch MP, Kuipers EJ, Spaander MC. Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer. Cochrane Database Syst Rev. 2017;11:CD004063. [PMID: 29182797 DOI: 10.1002/14651858.cd004063.pub4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
12 Wu SG, Zhang WW, He ZY, Sun JY, Chen YX, Guo L. Sites of metastasis and overall survival in esophageal cancer: a population-based study. Cancer Manag Res. 2017;9:781-788. [PMID: 29255373 DOI: 10.2147/cmar.s150350] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
13 Xu J, Lu D, Zhang L, Li J, Sun G. Palliative resection or radiation of primary tumor prolonged survival for metastatic esophageal cancer. Cancer Med 2019;8:7253-64. [PMID: 31612596 DOI: 10.1002/cam4.2609] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Weiss ARR, Donlon NE, Schlitt HJ, Hackl C. Resection of oesophageal and oesophagogastric junction cancer liver metastases - a summary of current evidence. Langenbecks Arch Surg 2021. [PMID: 34860291 DOI: 10.1007/s00423-021-02387-3] [Reference Citation Analysis]
15 Wu SG, He ZY, Wang Y, Sun JY, Lin HX, Su GQ, Li Q. Lymph node dissection improved survival in patients with metastatic thoracic esophageal cancer: An analysis of 220 patients from the SEER database. Int J Surg 2016;35:13-8. [PMID: 27613123 DOI: 10.1016/j.ijsu.2016.09.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
16 Fujinaka Y, Morita M, Ohga T, Kakeji Y, Yano T, Maehara Y. Definitive chemoradiotherapy and salvage esophagectomy for esophageal cancer associated with multiple lung metastases: a case report. Int Surg 2014;99:640-4. [PMID: 25216435 DOI: 10.9738/INTSURG-D-13-00123.1] [Reference Citation Analysis]
17 Wang J, Suri JS, Allen PK, Liao Z, Komaki R, Ho L, Hofstetter WL, Lin SH. Factors Predictive of Improved Outcomes With Multimodality Local Therapy After Palliative Chemotherapy for Stage IV Esophageal Cancer. Am J Clin Oncol 2016;39:228-35. [PMID: 24710122 DOI: 10.1097/COC.0000000000000066] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
18 Imura Y, Yamamoto S, Wakamatsu T, Tanaka T, Tamiya H, Sugimura K, Miyata H, Ishihara R, Yano M, Naka N. Clinical features and prognostic factors in patients with esophageal cancer with bone metastasis. Oncol Lett 2020;19:717-24. [PMID: 31897187 DOI: 10.3892/ol.2019.11142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
19 Schurink B, Mazza E, Ruurda JP, Roeling TAP, Bleys RLAW, van Hillegersberg R. Metastatic incidence of (PET)CT positive lung hilar and retroperitoneal lymph nodes in esophageal cancer patients. Surg Oncol 2020;33:170-6. [PMID: 32561084 DOI: 10.1016/j.suronc.2020.02.012] [Reference Citation Analysis]
20 Ai D, Zhu H, Ren W, Chen Y, Liu Q, Deng J, Ye J, Fan J, Zhao K. Patterns of distant organ metastases in esophageal cancer: a population-based study. J Thorac Dis. 2017;9:3023-3030. [PMID: 29221275 DOI: 10.21037/jtd.2017.08.72] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 5.6] [Reference Citation Analysis]
21 Liu M, Wang C, Gao L, Lv C, Cai X. A nomogram to predict long-time survival for patients with M1 diseases of esophageal cancer. J Cancer 2018;9:3986-90. [PMID: 30410603 DOI: 10.7150/jca.27579] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
22 Sakaguchi M, Maebayashi T, Aizawa T, Ishibashi N, Saito T. Clinical results of multimodality therapy for esophageal cancer with distant metastasis. J Thorac Dis 2018;10:1500-10. [PMID: 29707300 DOI: 10.21037/jtd.2018.03.45] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Shi M, Zhai GQ. Models for Predicting Early Death in Patients With Stage IV Esophageal Cancer: A Surveillance, Epidemiology, and End Results-Based Cohort Study. Cancer Control 2022;29:10732748211072976. [PMID: 35037487 DOI: 10.1177/10732748211072976] [Reference Citation Analysis]
24 Lyu J, Li T, Wang Q, Li F, Diao P, Liu L, Li C, Lang J. Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for stage IV esophageal squamous cell carcinoma: a retrospective controlled study. Radiat Oncol 2018;13:233. [PMID: 30477531 DOI: 10.1186/s13014-018-1183-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
25 Zhang L, Long X, Hu ZN, Wu Y, Song J, Zhang BX, Chen WX. An extremely atypical presentation of esophageal squamous cell carcinoma with pancreatic and hepatic metastases: A case report and overview of the literature. Medicine (Baltimore) 2021;100:e25785. [PMID: 34011038 DOI: 10.1097/MD.0000000000025785] [Reference Citation Analysis]
26 Liu Z, Zhang X, Li B, Jiang H, Yang Y, Hua R, Sun Y, Li Z. A population-based predictive model predicting candidate for primary tumor surgery in patients with metastatic esophageal cancer. J Thorac Dis 2021;13:870-82. [PMID: 33717560 DOI: 10.21037/jtd-20-2347] [Reference Citation Analysis]
27 Van Daele E, Scuderi V, Pape E, Van de Putte D, Varin O, Van Nieuwenhove Y, Ceelen W, Troisi R, Pattyn P. Long-term survival after multimodality therapy including surgery for metastatic esophageal cancer. Acta Chirurgica Belgica 2018;118:227-32. [DOI: 10.1080/00015458.2017.1411557] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]